• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ACE和ACE2中的新冠病毒多态性是预后预测指标吗?

Are COVID-19 Polymorphisms in ACE and ACE2 Prognosis Predictors?

作者信息

Guarienti Fabiana Amaral, Xavier Fernando Antônio Costa, Ferraz Mateus Duarte, Wagner Fernanda, Marinowic Daniel Rodrigo, da Costa Jaderson Costa, Machado Denise Cantarelli

机构信息

Post Graduation Program of Geriatrics and Gerontology, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre 90619, Brazil.

Laboratory of Molecular Biology and Immunology, Brain Institute of Rio Grande do Sul, Porto Alegre 90610, Brazil.

出版信息

Curr Issues Mol Biol. 2024 Jul 28;46(8):8111-8117. doi: 10.3390/cimb46080480.

DOI:10.3390/cimb46080480
PMID:39194697
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11352864/
Abstract

Regardless of the containment of the SARS-CoV-2 pandemic, it remains paramount to comprehensively understand its underlying mechanisms to mitigate potential future health and economic impacts, comparable to those experienced throughout the course of the pandemic. The angiotensin-converting enzyme 2 (ACE2) provides anchorage for SARS-CoV-2 binding, thus implicating that ACE and ACE2 might contribute to the variability in infection severity. This study aimed to elucidate predisposing factors influencing the disease course among people infected by SARS-CoV-2, focusing on angiotensin-converting enzyme (ACE) and ACE2 polymorphisms. Notably, despite similar demographics and comorbidities, COVID-19 patients exhibit substantial differences in prognosis. Genetic polymorphisms in ACE and ACE2 have been implicated in disease progression, prompting our investigation into their role in COVID-19 evolution. Using next-generation sequencing (NGS), we analyzed ACE and ACE2 genes in a sample group comprising six subjects infected by SARS-CoV-2. Our findings revealed a correlation between specific polymorphisms and COVID-19 outcomes. Specifically, ACE and ACE2 intronic deletions were observed in all deceased patients, suggesting a potential association with mortality. These results highlight the significance of genetic factors in shaping the clinical course of COVID-19, emphasizing the importance of further research into the impact of genetic variations on COVID-19 severity.

摘要

无论严重急性呼吸综合征冠状病毒2(SARS-CoV-2)大流行是否得到控制,全面了解其潜在机制对于减轻未来可能的健康和经济影响仍然至关重要,这些影响与大流行期间所经历的影响相当。血管紧张素转换酶2(ACE2)为SARS-CoV-2结合提供锚定,因此表明ACE和ACE2可能导致感染严重程度的差异。本研究旨在阐明影响SARS-CoV-2感染者疾病进程的易感因素,重点关注血管紧张素转换酶(ACE)和ACE2基因多态性。值得注意的是,尽管新冠肺炎患者的人口统计学特征和合并症相似,但他们在预后方面存在显著差异。ACE和ACE2基因多态性与疾病进展有关,这促使我们研究它们在新冠肺炎演变中的作用。我们使用下一代测序(NGS)技术,对一个由六名SARS-CoV-2感染者组成的样本组中的ACE和ACE2基因进行了分析。我们的研究结果揭示了特定基因多态性与新冠肺炎预后之间的相关性。具体而言,在所有死亡患者中均观察到ACE和ACE2内含子缺失现象,这表明其可能与死亡率有关。这些结果凸显了遗传因素在塑造新冠肺炎临床进程中的重要性,并强调了进一步研究基因变异对新冠肺炎严重程度影响的重要性。

相似文献

1
Are COVID-19 Polymorphisms in ACE and ACE2 Prognosis Predictors?ACE和ACE2中的新冠病毒多态性是预后预测指标吗?
Curr Issues Mol Biol. 2024 Jul 28;46(8):8111-8117. doi: 10.3390/cimb46080480.
2
Polymorphisms of ACE (I/D) and ACE2 receptor gene (Rs2106809, Rs2285666) are not related to the clinical course of COVID-19: A case study.ACE(I/D)和 ACE2 受体基因(Rs2106809、Rs2285666)多态性与 COVID-19 的临床病程无关:一项病例研究。
J Med Virol. 2021 Oct;93(10):5947-5952. doi: 10.1002/jmv.27160. Epub 2021 Jul 10.
3
Strong Association of Angiotensin Converting Enzyme-2 Gene Insertion/Deletion Polymorphism with Susceptibility to SARS-CoV-2, Hypertension, Coronary Artery Disease and COVID-19 Disease Mortality.血管紧张素转换酶2基因插入/缺失多态性与对严重急性呼吸综合征冠状病毒2的易感性、高血压、冠状动脉疾病及2019冠状病毒病死亡率的强关联
J Pers Med. 2021 Oct 27;11(11):1098. doi: 10.3390/jpm11111098.
4
ACE2 polymorphism and susceptibility for SARS-CoV-2 infection and severity of COVID-19.ACE2 多态性与 SARS-CoV-2 感染易感性和 COVID-19 严重程度。
Pharmacogenet Genomics. 2021 Oct 1;31(8):165-171. doi: 10.1097/FPC.0000000000000436.
5
Polymorphisms in ACE, ACE2, AGTR1 genes and severity of COVID-19 disease.ACE、ACE2、AGTR1 基因多态性与 COVID-19 疾病严重程度的关系。
PLoS One. 2022 Feb 4;17(2):e0263140. doi: 10.1371/journal.pone.0263140. eCollection 2022.
6
The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies.SARS-CoV-2 的受体 ACE-2 在许多不同的细胞类型上表达:对基于 ACE 抑制剂和血管紧张素 II 受体阻滞剂的心血管治疗的影响。
Intern Emerg Med. 2020 Aug;15(5):759-766. doi: 10.1007/s11739-020-02364-6. Epub 2020 May 19.
7
Polymorphisms in the human angiotensin converting enzyme gene (ACE) linked to susceptibility of COVID-19 and malaria infections in the Ghanaian population.人类血管紧张素转换酶基因(ACE)的多态性与加纳人群中 COVID-19 和疟疾感染的易感性有关。
Infect Genet Evol. 2024 Apr;119:105568. doi: 10.1016/j.meegid.2024.105568. Epub 2024 Feb 15.
8
and Gene Variants Are Associated With Severe Outcomes of COVID-19 in Men.并且基因变异与男性 COVID-19 的严重结局相关。
Front Immunol. 2022 Feb 17;13:812940. doi: 10.3389/fimmu.2022.812940. eCollection 2022.
9
Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).血管紧张素转化酶 2(ACE2)、严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)与 2019 冠状病毒病(COVID-19)的病理生理学。
J Pathol. 2020 Jul;251(3):228-248. doi: 10.1002/path.5471. Epub 2020 Jun 10.
10
Impact of ACE I gene insertion/deletion, A-240T polymorphisms and the renin-angiotensin-aldosterone system on COVID-19 disease.ACE I 基因插入/缺失、A-240T 多态性与肾素-血管紧张素-醛固酮系统对 COVID-19 疾病的影响。
Virol J. 2024 Jan 10;21(1):15. doi: 10.1186/s12985-023-02283-w.

引用本文的文献

1
Introduction to Special Issue: Genomic Analysis of Common Disease.特刊介绍:常见疾病的基因组分析
Curr Issues Mol Biol. 2025 Feb 10;47(2):112. doi: 10.3390/cimb47020112.

本文引用的文献

1
Association of ACE1 I/D polymorphism and susceptibility to COVID-19 in Egyptian children and adolescents.ACE1 I/D 多态性与埃及儿童和青少年 COVID-19 易感性的关联。
Pediatr Res. 2024 Oct;96(5):1347-1354. doi: 10.1038/s41390-023-02982-8. Epub 2024 Jan 4.
2
Predictive Factors and Gene Polymorphisms in Susceptibility to Long COVID-19 Syndrome.长新冠综合征易感性的预测因素和基因多态性。
Int J Mol Sci. 2023 Nov 24;24(23):16717. doi: 10.3390/ijms242316717.
3
Combinatorial analysis of ACE and ACE2 polymorphisms reveals protection against COVID-19 worsening: A genetic association study in Brazilian patients.ACE 和 ACE2 多态性的组合分析显示其可降低 COVID-19 恶化风险:巴西患者的一项遗传关联研究。
PLoS One. 2023 Nov 30;18(11):e0288178. doi: 10.1371/journal.pone.0288178. eCollection 2023.
4
TMPRSS2 polymorphism (rs12329760) and the severity of the COVID-19 in Iranian population.TMPRSS2 多态性(rs12329760)与伊朗人群中 COVID-19 的严重程度。
PLoS One. 2023 Feb 16;18(2):e0281750. doi: 10.1371/journal.pone.0281750. eCollection 2023.
5
Association of ACE2 Gene Variants with the Severity of COVID-19 Disease-A Prospective Observational Study.ACE2 基因变异与 COVID-19 疾病严重程度的关联:一项前瞻性观察研究。
Int J Environ Res Public Health. 2022 Oct 2;19(19):12622. doi: 10.3390/ijerph191912622.
6
Global distribution of ACE1 (rs4646994) and ACE2 (rs2285666) polymorphisms associated with COVID-19: A systematic review and meta-analysis.与 COVID-19 相关的 ACE1(rs4646994)和 ACE2(rs2285666)多态性的全球分布:系统评价和荟萃分析。
Microb Pathog. 2022 Nov;172:105781. doi: 10.1016/j.micpath.2022.105781. Epub 2022 Sep 15.
7
and Gene Variants Are Associated With Severe Outcomes of COVID-19 in Men.并且基因变异与男性 COVID-19 的严重结局相关。
Front Immunol. 2022 Feb 17;13:812940. doi: 10.3389/fimmu.2022.812940. eCollection 2022.
8
Angiotensin System Polymorphisms' in SARS-CoV-2 Positive Patients: Assessment Between Symptomatic and Asymptomatic Patients: A Pilot Study.新型冠状病毒肺炎阳性患者的血管紧张素系统多态性:有症状与无症状患者的评估:一项初步研究
Pharmgenomics Pers Med. 2021 May 27;14:621-629. doi: 10.2147/PGPM.S303666. eCollection 2021.
9
ACE2 polymorphism and susceptibility for SARS-CoV-2 infection and severity of COVID-19.ACE2 多态性与 SARS-CoV-2 感染易感性和 COVID-19 严重程度。
Pharmacogenet Genomics. 2021 Oct 1;31(8):165-171. doi: 10.1097/FPC.0000000000000436.
10
The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity.新冠病毒谜题:解析新疾病实体的病理生理学和表型。
Lancet Respir Med. 2021 Jun;9(6):622-642. doi: 10.1016/S2213-2600(21)00218-6. Epub 2021 May 6.